Status
Conditions
Treatments
About
The aim of the study is:
to develop a comprehensive biochemical assay for detection of Pompe disease (glycogen storage disease type II), to be implemented in the Newborn screening program among the Israeli population.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Loading...
Central trial contact
Hanna Mandel, Prof.; Mariel Kaplan, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal